Skip to main content
. 2024 Jun 1;42(1):365. doi: 10.1007/s00345-024-05050-w

Table 1.

Patients characteristics, IPSSscore,Q max, residual urine and QoL at presentation and 4 weeks

Total Responder
(n = 93)
Non-responder
(n = 18)
p-value
Age, years 63.12 ± 4.83 63.04 ± 4.67 63.50 ± 5.70 0.715
PSA, ng/ml 3.42 ± 0.93 3.42 ± 0.93 3.43 ± 0.96 0.946
IPSS total score
Baseline 24.03 ± 2.49 24.26 ± 2.46 22.83 ± 2.38
At 4 weeks 16.41 ± 3.84 15.14 ± 1.95 23.00 ± 4.49
p-value  < 0.001  < 0.001 0.815
Qmax (ml/sec)
Baseline 7.72 ± 1.64 7.64 ± 1.66 8.14 ± 1.49
At 4 weeks 12.08 ± 2.37 12.59 ± 1.71 9.47 ± 3.45
p-value  < 0.001  < 0.001 0.097
PVR (ml)
Baseline 108.84 ± 36.38 110.78 ± 15.38
At 4 weeks 60.02 ± 24.40 104.14 ± 42.88
p-value  < 0.001 0.524
QoL
Baseline 4.68 ± 0.77 4.69 ± 0.78 4.61 ± 0.69
At 4 weeks 4.08 ± 0.97 4.10 ± 0.99 3.89 ± 1.02
p-value  < 0.001  < 0.001 0.010

*t-test

**Paired Samples Correlations